Summit awarded Barda contract worth up to $62m

13:34 11/09/2017
StockMarketWire.com - Summit Therapeutics has announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded the Company a contract worth up to $62m.

It said the funds will support the clinical and regulatory development of ridinilazole for the treatment of CDI, including Summit's planned Phase 3 development program.

Glyn Edwards, Chief Executive Officer, commented:

"CDI is a serious public health threat that is a significant burden on the US population, and BARDA has committed to the development of innovative treatments capable of addressing all aspects of this serious illness, including recurrent disease. BARDA's selection of ridinilazole for an award is testament to ridinilazole's promising clinical and preclinical data package that indicate its potential as a front-line treatment of CDI that could reduce recurrent disease."

"This non-dilutive funding award begins to deliver on our strategy of maximizing the value of ridinilazole for patients with CDI, Summit and our shareholders, and we look forward to initiating the Phase 3 clinical program of ridinilazole."



At 1:34pm: (LON:SUMM) Summit Therapeutics PLC share price was +32.5p at 245p


Story provided by StockMarketWire.com

Forex

Commodities

What the Papers Say

telegraph financial times daily mail daily express independent times
22:42 Stratford acid attack: six people injured...
source: The Telegraph
22:25 Milo Yiannopoulos to hold rally...
source: The Telegraph
22:09 Stratford acid attack: six people injured...
source: The Telegraph
22:09 Stratford acid attack: six people injured...
source: The Telegraph
22:00 Ted Hughes, the 'brilliant, rugged...
source: The Telegraph
22:00 Government urged to do more to help foster...
source: The Telegraph
22:00 ‘When will this nightmare...
source: The Telegraph
21:53 Stratford acid attack: six people injured...
source: The Telegraph
21:24 London Mayor Sadiq Khan could be in breach...
source: The Telegraph
21:13 Prince Harry lets five-year-old fan take...
source: The Telegraph
[more ...]